Imagawa, Jun <br/><br/>
Switching from all-trans retinoic acid to arsenic trioxide for newly diagnosed acute promyelocytic leukemia.  [electronic resource] 

 -  Leukemia & lymphoma  12 2018 
 - 3013-3015 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2018.1443333  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Arsenic Trioxide--therapeutic use<br/>Disease Progression<br/>Disseminated Intravascular Coagulation--chemically induced<br/>Drug Substitution<br/>Humans<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Male<br/>Treatment Outcome<br/>Tretinoin--adverse effects